New team members

03. April 2023

BGPartner is pleased to welcome David Dalla Vecchia (Attorney-at-law at the Zurich office) and Anja Spahni (Trainee at the Berne office) 

as of April 1, 2023. Further information on our entire team can be found here.


Interested in how Swiss executives negotiate?

31. March 2023

BGPartner and the Negotiation Academy Potsdam of the Universität Potsdam wanted to find out and conducted the first comprehensive and representative study on this topic, with answers from more than 350 Swiss executives. A study with many insights and practical relevance and on how negotiations are conducted. The study “How do Swiss executives negotiate?” will be released on May 25, 2023. Mark your calendar!

Vis Moot Court Trial Round 2023

13. March 2023

This year we had the privilege of hosting the teams of Universität BernUniversité de Genève and University Zürich who did an outstanding job with their pleadings.

Find out in the After Movies what the students benefited most from, how realistic a trial round is, what the preparation looks like and why BGPartner continues to support this project.

After Movie (Office Berne) Universität Bern vs. Universität Genf

After Movie (Office Zurich) Universität Zürich

BGPartner advises co-lead investors Forbion and Jeito Capital in USD 112 millions Series B financing round of Noema Pharma Ltd

07. March 2023

Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system (CNS) disorders, successfully closed an oversubscribed Series B financing round, raising CHF 103 millions (approx. USD 112 millions).

The round was co-led by the European healthcare focused investment firms Forbion and JEITO Capital. UPMC Enterprises and an additional new investor joined existing investors Sofinnova PartnersPolaris Inc.Gilde Healthcare and The Invus Group to complete the round.

The proceeds of the Series B financing will be used to advance Noema Pharma’s clinical-stage assets. Following the closing of this Series B financing round, Nanna Lüneborg from Forbion and Rachel Mears from Jeito Capital will join the board of directors of Noema Pharma Ltd.

BGPartner advised co-lead investors Forbion and Jeito Capital on all Swiss legal matters and the negotiations of this Series B financing round. The core team consisted of Oliver Gnehm (Partner) and Victoria Marty (Associate) and furthermore comprised Olivier Bula (Partner), Fabiola Weilenmann-Anthamatten (Managing Associate) and Geremia Stüssi (Jurist).

More information can be found here.

LAWorld EMEA Meeting in Athens

02. March 2023

The answer to the question "what makes a professional network strong" is multifaceted. However, one thing is clear: a network is only as strong as the relationships among its members. And this is cultivated at LAWorld in the form of regular get-togethers.

The event proved once again that LAWorld is a unique and vibrant international legal network with strong ties amongst its highly professional members that go beyond any ordinary network.
An EMEA Meeting wouldn't be a LAWorld Meeting if we didn't also have fun and enjoy great times with our LAWorld friends. Thank’s again to our friends from the hosting law firm The Law Firm / Moutzouridou - Sakellariou & Associates for organizing a wonderful conference. It was a great pleasure for us.

The pictures of the after movie speak for themselves, enjoy watching it!